Quick Answer
InspireMD, Inc. reported R&D Expense of $15.00 million for fiscal year 2025.
InspireMD, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $15.00M | +10.0% |
| 2024 | $13.63M | +70.8% |
| 2023 | $7.98M | +2.2% |
| 2022 | $7.81M | +51.4% |
| 2021 | $5.16M | +131.0% |
| 2020 | $2.23M | -24.4% |
| 2019 | $2.95M | +92.4% |
| 2018 | $1.53M | +20.3% |
| 2017 | $1.28M | -1.2% |
| 2016 | $1.29M | -64.6% |
| 2015 | $3.64M | -58.3% |
| 2014 | $8.74M | +110.4% |
| 2013 | $4.16M | +4.2% |
| 2012 | $3.99M | +61.2% |
| 2011 | $2.47M | +84.9% |
| 2010 | $1.34M | +0.6% |
| 2009 | $1.33M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $3.63M | -7.2% | -5.2% |
| June 30, 2025 | $3.83M | +12.7% | -5.5% |
| March 31, 2025 | $4.06M | +54.6% | +3.7% |
| September 30, 2024 | $3.92M | +85.5% | +15.1% |
| June 30, 2024 | $3.40M | +70.6% | +29.6% |
| March 31, 2024 | $2.62M | +42.4% | +24.4% |
| September 30, 2023 | $2.11M | +2.4% | +5.9% |
| June 30, 2023 | $1.99M | -3.1% | +8.1% |
- InspireMD, Inc. showed an increase of +10.0% in R&D Expense compared to the prior fiscal year.
- Over the 2009–2025 period, InspireMD, Inc.’s r&d expense has grown by 1028.0% (from $1.33 million to $15.00 million).
- The most recent figure is from InspireMD, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 18, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: